• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS INFINITY LAB CORE LICENSE 3.X; CALCULATOR/DATA PROCESSING MODULE FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS INFINITY LAB CORE LICENSE 3.X; CALCULATOR/DATA PROCESSING MODULE FOR CLINICAL USE Back to Search Results
Medical Device Problem Code Application Program Problem (2880)
Health Effect - Clinical Code Viral Infection (2248)
Date of Event 03/28/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The investigation has confirmed the customer's allegation.The investigation is ongoing.
 
Event or Problem Description
There was an allegation of a positive hiv result being interpreted as negative on the cobas infinity core software for 1 patient sample.It was alleged that on (b)(6) 2022, a patient was tested for hiv.The result was allegedly reported in the infinity software as negative and this result was reported outside of the laboratory.After the patient¿s partner was determined to be hiv positive, the patient underwent further testing.In feb 2023, the patient was tested at another laboratory and found to be hiv positive.The original reporting laboratory was recently informed of the new patient result and investigated the discrepancy.
 
Additional Manufacturer Narrative
The reported allegation was verified as a software issue in cobas infinity.It was found that the software was not handling the repetition number of embedded results properly after the repetition was requested by a user that had missing permissions due to a software issue.The issues of the software not correctly assigning the permissions to embedded tests from a cobas e-flow and not correctly handling repetitions have been identified and are currently being addressed.The issue was identified as only occurring from 24-mar to 30-mar-2022.No further occurrences have been identified.The current workaround is to remove the permissions for the whole test group, including the e-flow test and assigning the tests one by one.Additionally, it is recommended to change the "automatic result for repetitions" parameter to the default value "no result" for all configured cobas e-flow tests.The issue was solved by editing the main test and creating a new version on 10-apr-2022.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS INFINITY LAB CORE LICENSE 3.X
Common Device Name
CALCULATOR/DATA PROCESSING MODULE FOR CLINICAL USE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE INSTRUMENT CENTER AG TEGIMENTA
forrenstrasse
na
rotkreuz 6343
SZ   6343
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16548129
Report Number1823260-2023-00815
Device Sequence Number12375218
Product Code JQP
UDI-Device Identifier07613336177129
UDI-Public07613336177129
Combination Product (Y/N)N
Initial Reporter CountrySZ
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 05/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/13/2023
Supplement Date Received by Manufacturer04/21/2023
04/20/2023
Initial Report FDA Received Date03/15/2023
Supplement Report FDA Received Date05/15/2023
05/25/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
RES 92085
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-